FDA Panel Recommends Moderna Coronavirus Vaccine

A Food and Drug Administration advisory panel voted Thursday to endorse Moderna’s coronavirus vaccine and recommended that the agency move forward with emergency authorization.

In a 20-0 vote, with one abstention, the panel found that the safety and efficacy of the vaccine outweigh the risks for use in people age 18 and older, marking the penultimate step in the approval process.